-transparent.png){kind=logo}
Infusion of 5'-dFUrd (2.0-3.0 g/m2 over 1 h on days 1-5 every 3rd week) resulted in one partial response in 21 patients with advanced and progressing colorectal cancer. No patient had received chemotherapy before the 5'-dFUrd trial. Hematological and gastrointestinal toxicity were generally mild. In 4 patients peripheral neurotoxicity was diagnosed during treatment, whereas transient cerebellopathy was observed in one. Cardiac side effects (repeated angina pectoris following 5'-dFUrd infusion) led to discontinuation of treatment after two courses in one patient. It is concluded that 5'-dFUrd at the above doses is not superior to conventional 5-FU treatment in colorectal cancer. Neurological and cardiac side effects are rare but may be a problem in individual patients.
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
May 1986,
Acta neurologica Scandinavica,
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
December 1983,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
September 2000,
Oncology,
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
March 1988,
European journal of cancer & clinical oncology,
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
January 1986,
Cancer chemotherapy and pharmacology,
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
October 1994,
Annals of oncology : official journal of the European Society for Medical Oncology,
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
January 1997,
Cancer chemotherapy and pharmacology,
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
January 1986,
Investigational new drugs,
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
June 1983,
Cancer treatment reports,
S D Fosså, and
O Dahl, and
R Hoel, and
M Heier, and
M Loeb
April 2001,
Cancer,
